A multinational phase II trial of bevacizumab with low-dose interferon- 2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN

✍ Scribed by Melichar, B.; Bracarda, S.; Matveev, V.; Alekseev, B.; Ivanov, S.; Zyryanov, A.; Janciauskiene, R.; Fernebro, E.; Mulders, P.; Osborne, S.; Jethwa, S.; Mickisch, G.; Gore, M.; van Moorselaar, R. J. A.; Staehler, M.; Magne, N.; Bellmunt, J.

• Book ID: 121486968
• Publisher: Oxford University Press
• Year: 2013
• Tongue: English
• Weight: 191 KB
• Volume: 24
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdt228